What's new

Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2025 Positive

Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2025 Positive

Feb 20, 2025 - 14:30
 0
Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2025 Positive
Orphan designation: Camostat mesilate Treatment of chronic pancreatitis, 16/01/2025 Positive
Read More

Tags:

Previous Article

Stellantis unveils STLA AutoDrive, hands-free and eyes-off autonomous technology...

Next Article

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, ...

Related Posts

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Minimum inhibitory concentration (MIC) breakpoints

Feb 21, 2025  0